Correlation Between Anebulo Pharmaceuticals and Codexis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Codexis, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Codexis.

Diversification Opportunities for Anebulo Pharmaceuticals and Codexis

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Anebulo and Codexis is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Codexis go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Codexis

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Codexis. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.04 times less risky than Codexis. The stock trades about -0.09 of its potential returns per unit of risk. The Codexis is currently generating about 0.36 of returns per unit of risk over similar time horizon. If you would invest  404.00  in Codexis on September 14, 2024 and sell it today you would earn a total of  159.00  from holding Codexis or generate 39.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  Codexis

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Codexis 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Codexis are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Codexis unveiled solid returns over the last few months and may actually be approaching a breakup point.

Anebulo Pharmaceuticals and Codexis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and Codexis

The main advantage of trading using opposite Anebulo Pharmaceuticals and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.
The idea behind Anebulo Pharmaceuticals and Codexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments